Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy

Koji Tanaka1, Haiyan Li, Peter J Curran

  • 1University of California, Los Angeles, Center for Health Sciences, Los Angeles, California, USA.

Insights

Percutaneous coronary intervention (PCI) for transplant coronary artery disease (CAD) shows acceptable outcomes in heart transplant recipients. Drug-eluting stents reduced restenosis, improving survival rates in this high-risk group.

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Interventional Cardiology

Background:

  • Progressive coronary vascular obliteration is a significant cause of late morbidity and mortality post-orthotopic heart transplantation.
  • Transplant coronary artery disease (CAD) management remains a challenge, with limited data on the long-term efficacy of percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To evaluate the longitudinal results and restenosis rates of PCI in patients with transplant CAD.
  • To identify factors influencing restenosis and survival after PCI in heart transplant recipients.

Main Methods:

  • Retrospective analysis of 65 heart transplant patients who underwent PCI for transplant CAD between 1993 and 2004.
  • Assessment of procedural success, angiographic follow-up, restenosis rates, and survival data.
  • Multivariate analysis of clinical, angiographic, and immunologic variables.

Main Results:

  • PCI procedural success rate was 93%.
  • The global restenosis rate was 36% at 9.5 months post-PCI.
  • Drug-eluting stents showed a lower restenosis rate (19%) compared to bare metal stents (31%).
  • The 5-year actuarial survival rate was 56% after the first PCI.

Conclusions:

  • PCI offers acceptable immediate and long-term results for transplant CAD, despite higher restenosis rates than in non-transplant patients.
  • Drug-eluting stents appear effective in reducing restenosis in the inflammatory environment of transplant CAD.
  • PCI may improve actuarial survival in orthotopic heart transplant recipients compared to historical controls.